Searched for
MSMES PHARMACEUTICAL REGULATIONS
Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
India’s development ladder after AI: What comes next?India’s future prosperity may increasingly depend on empowering its smaller economic units to become more productive using AI.
Over 60% of pharma MSMEs yet to comply with updated manufacturing normsPharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...
Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
Single-window system, project dashboard accelerate industrialisation in Odisha: IPICOL MDReforms streamline processes without diluting safeguards, says Aboli Sunil Naravane, MD, IPICOL
India-EU FTA to strengthen position of Indian formulations, medicines in EUA new India-EU free trade agreement promises to boost Indian pharmaceutical exports. Lower tariffs will make Indian medicines more competit...
Health Minister Nadda seeks 'workable solution' to Schedule M issueUnion Health Minister JP Nadda is working on a solution for the pharmaceutical industry. Drug regulator and department of pharmaceuticals a...
Ministry in talks with states to give some drug cos more time for good manufacturing practices complianceThe Union Health Ministry is in talks with states about extending the deadline for pharmaceutical companies to meet new manufacturing quali...
'Drug companies in upgrade mode need more time for GMP compliance': IDMAA pharma group is requesting more time for manufacturers to meet new quality standards. Many companies have started upgrades but face genui...
Himachal drug cos under stop orders found operationalHimachal Pradesh's drug regulation bodies came across a concerning trend: numerous pharmaceutical companies were found to be operating illi...
Small pharma firms may face closure as regulator tightens quality checksMany small drug makers face closure as regulators inspect facilities for quality standards. Thousands of plants may shut down if upgrades a...
Drug regulator for strict compliance with new Schedule MThe state drug regulators have been asked to submit monthly reports to the Central Drugs Standard Control Organisation on the inspections a...
ET MSME Awards 2025: India's pharma MSMEs face existential choiceNew bio-equivalence rules promise safer drugs but could eliminate pharma manufacturers that make medicines affordable. Is there a middle gr...
MSMEs show resilience with threefold export growth amid global challenges: ReportDespite global challenges, Indian MSME exports have surged threefold between 2020-21 and 2024-25, reaching INR 12.39 lakh crore.
Drug companies flag concerns over timeline for carrying out regulator's manufacturing ruleSmall and medium pharmaceutical companies are appealing to the health minister, raising concerns about stringent manufacturing standards im...
MSMEs demand supportive compliance frameworks as QCO burden mountsQuality norms should be designed to support MSMEs rather than stifle their growth, say industry leaders.
Risk-based audits of drug units to begin from July 1The revised Schedule M, which is considered more stringent than the World Health Organization's (WHO) good manufacturing practices (GMP) in...
Panel to examine if nutraceuticals can be produced within drug unitIn a significant development, a five-member expert committee has been appointed to assess the feasibility of allowing the manufacturing of ...
Compliance plays a big part in helping Indian MSMEs grow exportsWhile challenges persist, the compliance levels of Indian MSMEs in terms of export have been gradually improving, say experts.
New industrial policy for Karnataka: Business turnover, jobs added to decide state sopsOne of the focus areas of the policy, he said, is to develop an enabling ecosystem for technology adoption and innovation. The policy, the ...